5i89

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
'''Unreleased structure'''
 
-
The entry 5i89 is ON HOLD until Paper Publication
+
==Crystal structure of the bromodomain of human CREBBP bound to the benzodiazepinone G02857790==
-
 
+
<StructureSection load='5i89' size='340' side='right' caption='[[5i89]], [[Resolution|resolution]] 1.07&Aring;' scene=''>
-
Authors: Setser, J.W., Poy, F., Bellon, S.F.
+
== Structural highlights ==
-
 
+
<table><tr><td colspan='2'>[[5i89]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5I89 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5I89 FirstGlance]. <br>
-
Description: Crystal structure of the bromodomain of human CREBBP bound to the benzodiazepinone G02857790
+
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=69B:(4R)-6-(3-CYCLOPROPYL-1-METHYL-1H-INDAZOL-5-YL)-4-METHYL-1,3,4,5-TETRAHYDRO-2H-1,5-BENZODIAZEPIN-2-ONE'>69B</scene>, <scene name='pdbligand=ACT:ACETATE+ION'>ACT</scene>, <scene name='pdbligand=CA:CALCIUM+ION'>CA</scene></td></tr>
-
[[Category: Unreleased Structures]]
+
<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[5i83|5i83]], [[5i86|5i86]]</td></tr>
 +
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5i89 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5i89 OCA], [http://pdbe.org/5i89 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5i89 RCSB], [http://www.ebi.ac.uk/pdbsum/5i89 PDBsum]</span></td></tr>
 +
</table>
 +
== Disease ==
 +
[[http://www.uniprot.org/uniprot/CBP_HUMAN CBP_HUMAN]] Note=Chromosomal aberrations involving CREBBP may be a cause of acute myeloid leukemias. Translocation t(8;16)(p11;p13) with KAT6A; translocation t(11;16)(q23;p13.3) with MLL/HRX; translocation t(10;16)(q22;p13) with KAT6B. KAT6A-CREBBP may induce leukemia by inhibiting RUNX1-mediated transcription. Defects in CREBBP are a cause of Rubinstein-Taybi syndrome type 1 (RSTS1) [MIM:[http://omim.org/entry/180849 180849]]. RSTS1 is an autosomal dominant disorder characterized by craniofacial abnormalities, broad thumbs, broad big toes, mental retardation and a propensity for development of malignancies.<ref>PMID:11331617</ref> <ref>PMID:12114483</ref> <ref>PMID:12566391</ref> <ref>PMID:15706485</ref>
 +
== Function ==
 +
[[http://www.uniprot.org/uniprot/CBP_HUMAN CBP_HUMAN]] Acetylates histones, giving a specific tag for transcriptional activation. Also acetylates non-histone proteins, like NCOA3 and FOXO1. Binds specifically to phosphorylated CREB and enhances its transcriptional activity toward cAMP-responsive genes. Acts as a coactivator of ALX1 in the presence of EP300.<ref>PMID:9707565</ref> <ref>PMID:11154691</ref> <ref>PMID:12738767</ref> <ref>PMID:12929931</ref>
 +
== References ==
 +
<references/>
 +
__TOC__
 +
</StructureSection>
 +
[[Category: Bellon, S F]]
[[Category: Poy, F]]
[[Category: Poy, F]]
-
[[Category: Bellon, S.F]]
+
[[Category: Setser, J W]]
-
[[Category: Setser, J.W]]
+
[[Category: Bromodomain inhibitor]]
 +
[[Category: Protein binding-inhibitor complex]]

Revision as of 18:49, 12 May 2016

Crystal structure of the bromodomain of human CREBBP bound to the benzodiazepinone G02857790

5i89, resolution 1.07Å

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools